XULTOPHY

Solution for injection, 100j./ml + 3.6mg/ml
RxActive license

Active substance (INN)

insulin degludecliraglutide

Pharmaceutical form

Pharmaceutical formSolution for injection
Strength100j./ml + 3.6mg/ml
PackagingUkupno 5 napunjenih injekcionih penova sa po 3ml rastvora za injekciju u kartonskoj kutiji
ManufacturerNovo Nordisk A/S, Denmark
Therapeutic groupAlimentary tract and metabolism (A10AE56)
Marketing authorization holderNOVO NORDISK PHARMA OPERATIONS A/S, DANSKA - PREDSTAVNIŠTVO CRNA GORA PODGORICA
Authorization dateAugust 12, 2025

Analogs in Montenegro

7

Other medicines with the same active substance

Source: CInMED register